Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
17.36
-0.62 (-3.45%)
At close: Oct 13, 2026, 4:00 PM EDT
17.37
+0.01 (0.06%)
After-hours: Oct 13, 2026, 7:30 PM EDT
Relay Therapeutics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Relay Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $27.58. The average 1-year stock price forecast is 58.87% higher than the current stock price, while the lowest is $20 (+15.21%) and the highest is $32 (+84.33%).
Price Target: $27.58 (+58.87%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 10 | 11 | 11 | 10 | 10 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $25 | Buy | Maintains | $25 | +44.01% | Oct 12, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $20 | Buy | Maintains | $20 | +15.21% | Sep 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $28 → $29 | Buy | Reiterates | $28 → $29 | +67.05% | Aug 20, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $28 → $31 | Buy | Maintains | $28 → $31 | +78.57% | Aug 14, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $21 → $26 | Buy | Maintains | $21 → $26 | +49.77% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
11.16M
from 15.36M
Decreased by -27.32%
Revenue Next Year
17.91M
from 11.16M
Increased by 60.51%
EPS This Year
-1.61
from -1.61
EPS Next Year
-1.63
from -1.61
EPS and Forward PE are based on non-GAAP adjusted numbers.